Gain Therapeutics (GANX) SEC Filings & 10K Form

$3.07
-0.12 (-3.76%)
(As of 05:12 PM ET)

Recent Gain Therapeutics SEC Filings

DateFilerForm TypeView
04/08/2024
6:42 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/08/2024
6:44 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:23 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
8:00 PM
Alder Matthias (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:05 PM
Gain Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
8:30 PM
Alder Matthias (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
8:30 PM
Fuggetta Gianluca (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
6:00 AM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
4:26 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
3:09 PM
Gain Therapeutics (Filer)
Form 424B3
01/01/2024
11:15 PM
Gain Therapeutics (Filer)
Form EFFECT
12/19/2023
3:52 PM
Gain Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/24/2023
5:07 AM
Gain Therapeutics (Filer)
Form 424B5
11/22/2023
4:27 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
3:22 PM
Gain Therapeutics (Filer)
Form 424B5
11/17/2023
3:27 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:05 PM
Gain Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2023
3:02 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
3:36 PM
Alder Matthias (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:34 PM
Gain Therapeutics (Issuer)
RICHMAN ERIC I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:34 PM
Alder Matthias (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:38 PM
Gain Therapeutics (Issuer)
Melincoff Gwen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:38 PM
Gain Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:39 PM
Gain Therapeutics (Issuer)
Riley Jeffrey Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:40 PM
Gain Therapeutics (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:36 PM
Gain Therapeutics (Issuer)
HASLER HANS PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:37 PM
Gain Therapeutics (Issuer)
Nicaise Claude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
7:02 AM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2023
7:05 AM
Gain Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:GANX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners